Januvia Lawsuit Web site Launched by Bernstein Liebhard LLP to Give Information About Possible Januvia Side Effects, Such as Januvia Pancreatic Cancer


New York, New York (PRWEB) July 03, 2013

A new Januvia lawsuit internet site has been launched by Bernstein Liebhard LLP to supply details to men and women who might be concerned about potential Januvia side effects, such as Januvia pancreatic cancer, Januvia pancreatitis and Januvia thyroid cancer. The internet site will also be updated regularly with the most existing data concerning the increasing litigation surrounding the type 2 diabetes drug and its alleged association with pancreatic cancer, pancreatitis, and thyroid cancer.

&#13

Januvia and comparable variety 2 diabetes drugs are coming beneath elevated scrutiny amid concerns that they may possibly boost the danger that a patient will develop pancreatic cancer, pancreatitis or thyroid cancer. This site will offer valuable info to worried sufferers and their households concerning the prospective risks connected with Januvia, as effectively as their choices for legal recourse, says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and healthcare devices. The Firm is currently offering free of charge Januvia lawsuit consultations to any person who might have been harmed right after taking Januvia or a similar drug.

&#13

Januvia Lawsuits

&#13

Januvia belongs to a class of type2 diabetes drugs identified as incretin mimetics, which support regulate blood sugar by stimulating insulin production by the pancreas. The U.S. Food &amp Drug Administration (FDA) announced in March that it was investigating incretin mimetics following benefits from an unpublished study indicated these drugs may possibly cause pre-cancerous adjustments in the pancreas.* Most recently, a report published June 10th in the British Health-related Journal revealed previously unpublished information that indicated the producers of incretin mimetics could have downplayed the drugs possible to harm the pancreas.**

&#13

In 2009, a caution relating to a possible Januvia pancreatitis threat was added to the drugs label right after the FDA became conscious of 88 post-advertising cases of acute pancreatitis in individuals taking Januvia.*** In 2011, a study published in Gastroenterology discovered that use of Januvia appeared to increase the danger of pancreatitis and pancreatic cancer, while two circumstances of thyroid cancer have been also reported in the individuals who took Januvia.****

&#13

Court documents indicate that Merck &amp Co. has been named in a quantity of lawsuits filed on behalf of individuals who allegedly developed Januvia pancreatic cancer, Januvia pancreatitis, or Januvia thyroid cancer. The U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled to hear Oral Arguments on July 25, 2013, relating to the proposed establishment of a multidistrict litigation for all federally-filed claims involving incretin mimetics, Which includes Januvia lawsuits. (In Re: Incretins Items Liability, Sales and Advertising and marketing Litigation, MDL 2452, JPML)

&#13

Individuals who have allegedly developed Januvia pancreatic cancer, thyroid cancer or pancreatitis could be entitled to compensation for medical bills, lost wages, pain and suffering and far more. To learn more about filing a Januvia lawsuit, please check out Bernstein Liebhard LLPs internet site. For a lot more info, please call 800-511-5092.

&#13

*fda.gov/Drugs/DrugSafety/ucm343187.htm&#13

**bmj.com/open-data/incretin#alternate BMJ, June 10, 2013&#13

**fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm183800.htm September 25, 2009 &#13

***gastrojournal.org/article/S0016-5085%2811%2900172-7/abstract, Gastroenterology, February 21, 2011

&#13

About Bernstein Liebhard LLP &#13

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex person and class action lawsuits nationwide considering that 1993, including these who have been harmed by hazardous drugs, defective health-related devices and consumer items. The firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the leading plaintiffs firms in the country, for the previous ten consecutive years.

&#13

Bernstein Liebhard LLP &#13

10 East 40th Street &#13

New York, New York 10016 &#13

800-511-5092

&#13

Lawyer Marketing.

Bernstein Liebhard LLP Investigating Diabetes Drug Lawsuits Involving Byetta, Januvia, Victoza and Similar Medications


New York, New York (PRWEB) June 16, 2013

The nationwide law firm of Bernstein Liebhard LLP is investigating diabetes drug lawsuits on behalf of individuals treated with Byetta, Januvia, Victoza and other medications recognized as incretin mimetics, and who have been diagnosed with pancreatitis, pancreatic cancer or thyroid cancer. Type II diabetics who had been treated with an incretin mimetic and who have been diagnosed with a single of these illnesses may be entitled to compensation for health-related bills, lost wages, discomfort and suffering and other damages. Medicines integrated in the Firms diabetes drug lawsuit investigation incorporate:&#13

&#13